Telemetry Investments, L.L.C. Kal Vista Pharmaceuticals, Inc. Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$16.51 - $31.1 $410,818 - $773,861	-24,883 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $143,993 - $213,724	8,883 Added 55.52%	24,883 $491,000
Q3 2018 Nov 14, 2018	SELL	$8.0 - $22.11 $312,832 - $864,589	-39,104 Reduced 70.96%	16,000 $354,000
Q2 2018 Aug 14, 2018	BUY	$7.79 - $9.84 $429,260 - $542,223	55,104 New	55,104 $447,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.